PNTG — Pennant Group, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1766400 ·
Last close
$36.50
Market Cap
$1.28B
52W High
$44.24
52W Low
$25.57
ADV30
427,915
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 302,251,000 | 40,324,000 | 16,008,000 | 9,637,000 | 1,042,819,000 | 18,389,000 | 623,054,000 |
| Jun 2026 | 297,984,000 | 41,921,000 | 17,195,000 | 9,082,000 | 1,037,291,000 | 15,273,000 | 632,849,000 |
| Mar 2026 | 285,364,000 | 39,604,000 | 17,301,000 | 8,519,000 | 956,484,000 | 4,912,000 | 567,048,000 |
| Dec 2025 | 289,323,000 | 39,273,000 | 17,570,000 | 8,637,000 | 968,179,000 | 17,024,000 | 593,927,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$64,505,000
Investing CF
$-221,471,000
Financing CF
$173,019,000
CapEx
$-30,155,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.99
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$114,038,000
Inventory
—
Receivables
$130,836,000
ST Investments
—
EBIT TTM
$70,674,000
Pretax Income TTM
$57,386,000
Interest Exp TTM
$13,288,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,174,921,984
EBITDA
$83,563,000
Free Cash Flow
$-8,019,625
Enterprise Value
$1,791,903,744
Total Cash
$18,389,000
Total Debt
$488,932,000
Shares Out
35,132,364
Trailing EPS
$1.01
Book Value
$10.66
ROE
11.2%
ROA
5.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 947,705,000 | 50,887,000 | 29,578,000 | 968,179,000 | 593,927,000 | 332,603,000 | 48,294,000 |
| Dec 2024 | 695,240,000 | 37,434,000 | 22,559,000 | 679,521,000 | 367,556,000 | 293,283,000 | 39,298,000 |
| Dec 2023 | 544,891,000 | 25,239,000 | 13,379,000 | 539,691,000 | 394,176,000 | 140,339,000 | 33,090,000 |
| Dec 2022 | 473,241,000 | 19,704,000 | 6,643,000 | 512,119,000 | 386,462,000 | 121,012,000 | 9,044,000 |
TTM Snapshot
Revenues TTM
$1,101,710,000
NetIncome TTM
$32,319,000
OpCashFlow TTM
—
Assets (Latest)
$1,037,291,000
Forward EPS
$1.59
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $35.00 · spot: $35.81 · call volume: 9 · put volume: 2Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INNV | InnovAge Holding Corp. | $1.29B | $9.42 | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.41B | $14.63 | — |
| WGS | GeneDx Holdings Corp. | $1.42B | $47.29 | — |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.45B | $97.34 | — |
| FRNM | Freenome, Inc. | $1.09B | $9.82 | — |
News headlines (Yahoo Finance, 1h cache)
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
2026-11-13 17:25 · Yahoo
Pennant: 3 Key Takeaways for Long-Term Investors
2026-11-09 16:32 · Yahoo
Pennant Group (PNTG) Q3 2026 Earnings Call Transcript
2026-11-09 15:32 · Yahoo
The Pennant Group’s Q3 2026 earnings call: our top 5 analyst questions
2026-11-09 02:37 · Yahoo
What The Pennant Group (PNTG) Said on Its Q3 Earnings Call
2026-11-06 15:14 · Yahoo
Pennant Group (PNTG) Earnings Beat Keeps Fair Value In Focus
2026-11-06 12:16 · Yahoo
Pennant Group Inc (PNTG) Q3 2026 Earnings Call Highlights: Revenue Jumps 32% as Home Health and ...
2026-11-06 01:19 · Yahoo
The Pennant Group (NASDAQ:PNTG) beats Q3 2026 sales expectations
2026-11-04 22:44 · Yahoo
Pennant Reports Third Quarter 2026 Results
2026-11-04 21:05 · Yahoo
Pennant Announces Third Quarter 2026 Earnings Release and Call
2026-11-03 23:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.